Kawasaki Disease in Infants & Young Children - HealthyChildren.org
Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Scientific Statement for Health Professionals From the American Heart Association | Circulation
Kawasaki Disease An Update of diagnosis and treatment
Revised recommendations of the Italian Society of Pediatrics about the general management of Kawasaki disease | Italian Journal of Pediatrics | Full Text
Treatment Options for Refractory Kawasaki Disease
Mortality among Children with Kawasaki Disease in Japan | NEJM
National consensus on the cardiological treatment and follow-up of Kawasaki disease | Anales de Pediatría
Management of Kawasaki disease | Archives of Disease in Childhood
A Cost Comparison of Infliximab Versus Intravenous Immunoglobulin for Refractory Kawasaki Disease Treatment | American Academy of Pediatrics
Treatment of Kawasaki disease | Download Table
Kawasaki Disease - Current Understanding of the Mechanism and Evidence-Based Treatment | Ben Tsutomu Saji | Springer
emDOCs.net – Emergency Medicine EducationEM in 5: Kawasaki Disease - emDOCs.net - Emergency Medicine Education
Intravenous Immunoglobulin for the Treatment of Kawasaki Disease | Pediatric Annals
Kawasaki Disease: Complications and Treatment | American Heart Association
National consensus on the cardiological treatment and follow-up of Kawasaki disease | Anales de Pediatría
Refractory Kawasaki disease: diagnostic and management challenges | PHMT
Treatment of Kawasaki disease | Download Table
Acute Kawasaki Disease Therapy | Semantic Scholar
Understanding Kawasaki Disease
Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Scientific Statement for Health Professionals From the Ame
Kawasaki disease: AHA statement and recommendations
Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease | Circulation
Diagnosis and Management of Kawasaki Disease - American Family Physician
Kawasaki Disease: An Update on Diagnosis and Treatment - Pediatrics & Neonatology
Pediatric Diseases:Kawasaki Disease | Treatment of disorder | Tokushukai Group
Efficacy of primary treatment with immunoglobulin plus ciclosporin for prevention of coronary artery abnormalities in patients with Kawasaki disease predicted to be at increased risk of non-response to intravenous immunoglobulin (KAICA): a